dc.contributor.author
Budde, Klemens
dc.contributor.author
Halleck, Fabian
dc.date.accessioned
2022-03-16T11:54:10Z
dc.date.available
2022-03-16T11:54:10Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/34418
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-34136
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
Mycophenolic Acid
en
dc.subject
Risk Assessment
en
dc.subject
Kidney Transplantation
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Risks and benefits of everolimus
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1111/tri.13489
dcterms.bibliographicCitation.journaltitle
Transplant International
dcterms.bibliographicCitation.number
11
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
1124
dcterms.bibliographicCitation.pageend
1126
dcterms.bibliographicCitation.volume
32
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31397931
dcterms.isPartOf.issn
0934-0874
dcterms.isPartOf.eissn
1432-2277